Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Conference Coverage

melanoma
Conference Coverage
Pre-Existing Therapies and More Down the Pipeline: Updates in Melanoma
10/21/2022
Jessica Garlewicz, Associate Digital Editor
During her session at the 2022 Fall Clinical Dermatology Conference, Laura K. Ferris, MD, PhD, went over the importance of immunotherapy, collaborative care, and more when treating patients with melanoma.
During her session at the 2022 Fall Clinical Dermatology Conference, Laura K. Ferris, MD, PhD, went over the importance of immunotherapy, collaborative care, and more when treating patients with melanoma.
During her session at the 2022...
10/21/2022
The Dermatologist

Advertisement

Elizabeth Swanson, MD
Conference Coverage
Pediatric Dermatology: Psoriasis, Atopic Dermatitis, and More
10/21/2022
Jessica Garlewicz, Associate Digital Editor
In her session, “What's New and Hot in Pediatric Dermatology,” Elizabeth Swanson, MD, shared her experiences and tips on treating pediatric patients within her clinic.
In her session, “What's New and Hot in Pediatric Dermatology,” Elizabeth Swanson, MD, shared her experiences and tips on treating pediatric patients within her clinic.
In her session, “What's New and...
10/21/2022
The Dermatologist
Linda F. Stein Gold, MD
Conference Coverage
From Psoriasis to Atopic Dermatitis: Insights Into Topical Therapy
10/21/2022
Jessica Garlewicz, Associate Digital Editor
During her session, “What's New and Hot in Topical Therapy,” Linda F. Stein Gold, MD, imparted some of the best practices physicians can implement when using topical therapy in their clinic.
During her session, “What's New and Hot in Topical Therapy,” Linda F. Stein Gold, MD, imparted some of the best practices physicians can implement when using topical therapy in their clinic.
During her session, “What's New...
10/21/2022
The Dermatologist
atopic dermatitis
Conference Coverage
What’s New and Hot in Atopic Dermatitis?
10/21/2022
Coleen Stern, MA, Senior Managing Editor
In her session, “What’s New and Hot in Atopic Dermatitis,” Emma Guttman-Yassky, MD, PhD, reviewed recent targeted therapies for the treatment of atopic dermatitis.
In her session, “What’s New and Hot in Atopic Dermatitis,” Emma Guttman-Yassky, MD, PhD, reviewed recent targeted therapies for the treatment of atopic dermatitis.
In her session, “What’s New and...
10/21/2022
The Dermatologist

Advertisement

Acne
Conference Coverage
What's Hot in Acne and Rosacea?
10/21/2022
Coleen Stern, MA, Senior Managing Editor
Valerie D. Callender, MD, FAAD, reviewed new topical medications and laser therapies in her session, “What’s Hot in Acne and Rosacea,” on the second day of Fall Clinical 2022.
Valerie D. Callender, MD, FAAD, reviewed new topical medications and laser therapies in her session, “What’s Hot in Acne and Rosacea,” on the second day of Fall Clinical 2022.
Valerie D. Callender, MD, FAAD,...
10/21/2022
The Dermatologist
April W. Armstrong, MD, MPH
Conference Coverage
IL-17 Inhibitors: Psoriasis and Beyond
10/21/2022
Jessica Garlewicz, Associate Digital Editor
In their session presented at the 2022 Fall Clinical Dermatology Conference, April W. Armstrong, MD, MPH, and Bruce E. Strober, MD, PhD, shared insights into the roles of IL-17 inhibitors.
In their session presented at the 2022 Fall Clinical Dermatology Conference, April W. Armstrong, MD, MPH, and Bruce E. Strober, MD, PhD, shared insights into the roles of IL-17 inhibitors.
In their session presented at...
10/21/2022
The Dermatologist
Raj Chovatiya
Conference Coverage
Use of Steroids in Topical Psoriasis Therapy
10/21/2022
Riya Gandhi, MA, Associate Editor
Raj Chovatiya, MD, PhD, and Neal Bhatia, MD, kicked off their session, “The Use of Steroids in Topical Psoriasis Therapy,” by addressing the question: Why do we need another topical therapy? Lack of efficacy was one of the reasons.
Raj Chovatiya, MD, PhD, and Neal Bhatia, MD, kicked off their session, “The Use of Steroids in Topical Psoriasis Therapy,” by addressing the question: Why do we need another topical therapy? Lack of efficacy was one of the reasons.
Raj Chovatiya, MD, PhD, and Neal...
10/21/2022
The Dermatologist

Advertisement

Hilary Baldwin
Conference Coverage
Patient-Centered Acne Care
10/20/2022
Coleen Stern, MA, Senior Managing Editor
In their Fall Clinical 2022 in-depth seminar, “Topical Therapies for Acne Management: Evolving Skin One Patient at a Time,” Hilary Baldwin, MD, and James Q. Del Rosso, DO, identified patients who would benefit from topical acne treatments.
In their Fall Clinical 2022 in-depth seminar, “Topical Therapies for Acne Management: Evolving Skin One Patient at a Time,” Hilary Baldwin, MD, and James Q. Del Rosso, DO, identified patients who would benefit from topical acne treatments.
In their Fall Clinical 2022...
10/20/2022
The Dermatologist
swanson
Conference Coverage
Down the Pipeline: JAK Inhibitors in Atopic Dermatitis
10/20/2022
Jessica Garlewicz, Associate Digital Editor
During their session at 2022 Fall Clinical, James Q. Del Rosso, DO, and Elizabeth Swanson, MD, went over the current JAK inhibitors available to patients with AD.
During their session at 2022 Fall Clinical, James Q. Del Rosso, DO, and Elizabeth Swanson, MD, went over the current JAK inhibitors available to patients with AD.
During their session at 2022...
10/20/2022
The Dermatologist
Psoriasis rash
Conference Coverage
Generalized Pustular Psoriasis: A Rare and Devastating Disease
10/20/2022
Coleen Stern, MA, Senior Managing Editor
In their session on the first day of Fall Clinical 2022, “Working Together to Diagnose and Manage Patients with Generalized Pustular Psoriasis,” Boni E. Elewski, MD, and Alice B. Gottlieb, MD, PhD, were joined by patient speaker Jordan Hicks.
In their session on the first day of Fall Clinical 2022, “Working Together to Diagnose and Manage Patients with Generalized Pustular Psoriasis,” Boni E. Elewski, MD, and Alice B. Gottlieb, MD, PhD, were joined by patient speaker Jordan Hicks.
In their session on the first...
10/20/2022
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Current Issue

August 2024
Volume 32
Issue 5
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

Positive Phase III Data for Advanced Melanoma Treatment
10/20/2014
Positive results from CheckMate-037, a Phase III, randomized, controlled, open-label study of nivolumab (Opdivo, Bristol-Myers Squibb), versus investigator’s choice chemotherapy (ICC) in patients with advanced melanoma who were previously...
Positive results from CheckMate-037, a Phase III, randomized, controlled, open-label study of nivolumab (Opdivo, Bristol-Myers Squibb), versus investigator’s choice chemotherapy (ICC) in patients with advanced melanoma who were previously...
Positive results from...
10/20/2014
The Dermatologist
Chief Medical Editor Message
Navigating the Turbulent Health Care System
04/18/2017
Steve R. Feldman, MD, PhD
Our system of third-party payment has, for many years, struck me as fundamentally flawed.
Our system of third-party payment has, for many years, struck me as fundamentally flawed.
Our system of third-party...
04/18/2017
The Dermatologist
The Relevance of Vehicle in Low-Potency Topical Steroids: 2 Case Studies of Pruritic Condition
07/25/2014
07/25/2014
The Dermatologist
News
Psoriasis Treatment Improves Skin Clearance in Biologic Naïve Patients
03/14/2017
Patients with moderate plaque psoriasis, who were naïve to systemic biologic therapy, showed significantly improved skin clearance when treated with the oral, selective inhibitor of phosphodiesterase 4 apremilast (Otezla; Celgene Corp),...
Patients with moderate plaque psoriasis, who were naïve to systemic biologic therapy, showed significantly improved skin clearance when treated with the oral, selective inhibitor of phosphodiesterase 4 apremilast (Otezla; Celgene Corp),...
Patients with moderate plaque...
03/14/2017
The Dermatologist
New Topical Onychomycosis Treatment Approved
06/13/2014
Efinaconazole 10% topical solution (Jublia, Valeant Pharmaceuticals North America LLC, received approval as the first topical triazole approved for the treatment of onychomycosis of the toenails. The licensor and business partner for...
Efinaconazole 10% topical solution (Jublia, Valeant Pharmaceuticals North America LLC, received approval as the first topical triazole approved for the treatment of onychomycosis of the toenails. The licensor and business partner for...
Efinaconazole 10% topical...
06/13/2014
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

The Dermatologist Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Latest Quizzes and Trivia

Quiz
QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis
08/10/2024
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola...
08/10/2024
The Dermatologist
contact dermtitis + Neck + Eczema + rash
Quiz
QUIZ: Patient Experiences in Contact Dermatitis and Patch Testing
07/14/2024
What is a common challenge for patients during the patch testing week?
What is a common challenge for patients during the patch testing week?
What is a common challenge for...
07/14/2024
The Dermatologist
gloves hands
Quiz
Quiz: Barrier to Mental Health Support in Patients with Atopic Dermatitis
05/30/2024
Riya Gandhi, MA, Associate Editor
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview...
05/30/2024
The Dermatologist
Atopic dermatitis
Quiz
Quiz: Atopic Dermatitis Spotlight
05/06/2024
Riya Gandhi, MA, Associate Editor
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications...
05/06/2024
The Dermatologist
basal cell carcinoma
Quiz
True or False: Basal Cell Carcinoma on Vermilion Lip
05/01/2024
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the...
05/01/2024
The Dermatologist
Atopic Dermatitis + Eczema + Itch + Rash + Kids + Legs + Elbow + Knee
Quiz
Quiz: Navigating New Therapies in Atopic Dermatitis
04/10/2024
Riya Gandhi, MA, Associate Editor
In a recent interview, Dr Jonathan Silverberg, mentioned the importance of understanding the strengths and weaknesses of new therapies. Which aspect did he particularly emphasize as crucial in clinical practice?
In a recent interview, Dr Jonathan Silverberg, mentioned the importance of understanding the strengths and weaknesses of new therapies. Which aspect did he particularly emphasize as crucial in clinical practice?
In a recent interview, Dr...
04/10/2024
The Dermatologist
AD
Quiz
Trivia: Atopic Dermatitis Patients With Alopecia Areata
02/28/2024
Riya Gandhi, MA, Associate Editor
02/28/2024
The Dermatologist
AD
Quiz
Trivia: Itch Cycle and OTC Products
12/27/2023
12/27/2023
The Dermatologist
psoriasis
Quiz
Trivia: Recommended Treatment For Psoriasis
12/20/2023
Jessica Garlewicz, Digital Managing Editor
When treating mild to moderate and moderate to severe plaque psoriasis, what is the recommended treatment?
When treating mild to moderate and moderate to severe plaque psoriasis, what is the recommended treatment?
When treating mild to moderate...
12/20/2023
The Dermatologist
Ilka Arun Netravali, MD, PhD, FAAD
Quiz
Dupilumab Mechanism of Action
11/07/2023
Jessica Garlewicz, Digital Managing Editor
According to a recent interview with Dr Ilka Arun Netravali, what is the mechanism of action behind dupilumab that translates to effective suppression of atopic disease?
According to a recent interview with Dr Ilka Arun Netravali, what is the mechanism of action behind dupilumab that translates to effective suppression of atopic disease?
According to a recent interview...
11/07/2023
The Dermatologist

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use